Margaret Billingsley

Assistant Professor of Biomedical Engineering at University of Virginia – Lab Website coming soon

With a strong background in targeted drug delivery, immune cell engineering, and biomaterials, my future lab will develop nanoparticle platforms to precisely modulate immune cell populations while building a deeper understanding of nanoparticle-cell interactions.

This work will include nanoparticle formulation optimization and surface modifications combined with high throughput analyses and single cell sequencing to establish relationships between nanoparticle design and immune cell response. Ultimately, the insights from this work will inform the rational design of lipid nanoparticle platforms for applications in cancer immunotherapy, autoimmune disease, reproductive health, and beyond.

Transitional funding through the BWF CASI Award.